FDAnews Drug Daily Bulletin

NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA

June 27, 2006
A A

Nastech Pharmaceutical Company Inc. entered a agreement with Amylin Pharmaceuticals, Inc. to develop a nasal spray formulation of exenatide. StreetInsider.com (http://www.streetinsider.com/news.php?id=988986&st=p)